Analytics Link Ecosystem
IQVIA Analytics Link Ecosystem establishes deep connections across our key data assets.
SOLUTIONS
-
Research & Development
-
Real World Evidence
-
Commercialization
-
Safety & Regulatory Compliance
-
Technologies
LIFE SCIENCE SEGMENTS
HEALTHCARE SEGMENTS
- Information Partner Services
- Financial Institutions
- Global Health
- Government
- Patient Associations
- Payers
- Providers
THERAPEUTIC AREAS
- Cardiovascular
- Cell and Gene Therapy
- Central Nervous System
- GI & Hepatology
- Infectious Diseases and Vaccines
- Oncology & Hematology
- Pediatrics
- Rare Diseases
- View All
Impacting People's Lives
"We strive to help improve outcomes and create a healthier, more sustainable world for people everywhere.
LEARN MORE
Harness the power to transform clinical development
Reimagine clinical development by intelligently connecting data, technology, and analytics to optimize your trials. The result? Faster decision making and reduced risk so you can deliver life-changing therapies faster.
Research & Development OverviewResearch & Development Quick Links
Real World Evidence. Real Confidence. Real Results.
Generate and disseminate evidence that answers crucial clinical, regulatory and commercial questions, enabling you to drive smarter decisions and meet your stakeholder needs with confidence.
REAL WORLD EVIDENCE OVERVIEWReal World Evidence Quick Links
See markets more clearly. Opportunities more often.
Elevate commercial models with precision and speed using AI-driven analytics and technology that illuminate hidden insights in data.
COMMERCIALIZATION OVERVIEWCommercialization Quick Links
Service driven. Tech-enabled. Integrated compliance.
Orchestrate your success across the complete compliance lifecycle with best-in-class services and solutions for safety, regulatory, quality and medical information.
COMPLIANCE OVERVIEWSafety & Regulatory Compliance Quick Links
Intelligence that transforms life sciences end-to-end.
When your destination is a healthier world, making intelligent connections between data, technology, and services is your roadmap.
TECHNOLOGIES OVERVIEWTechnology Quick Links
CLINICAL PRODUCTS
COMMERCIAL PRODUCTS
COMPLIANCE, SAFETY, REG PRODUCTS
BLOGS, WHITE PAPERS & CASE STUDIES
Explore our library of insights, thought leadership, and the latest topics & trends in healthcare.
DISCOVER INSIGHTSTHE IQVIA INSTITUTE
An in-depth exploration of the global healthcare ecosystem with timely research, insightful analysis, and scientific expertise.
SEE LATEST REPORTSFEATURED INNOVATIONS
-
IQVIA Connected Intelligence™
-
IQVIA Healthcare-grade AI®
-
IQVIA AI Assistant
-
Human Data Science Cloud
-
IQVIA Innovation Hub
-
Decentralized Trials
-
Patient Experience Solutions with Apple devices
WHO WE ARE
- Our Story
- Our Impact
- Commitment to Global Health
- Code of Conduct
- Sustainability
- Privacy
- Executive Team
NEWS & RESOURCES
Unlock your potential to drive healthcare forward
By making intelligent connections between your needs, our capabilities, and the healthcare ecosystem, we can help you be more agile, accelerate results, and improve patient outcomes.
LEARN MORE
IQVIA AI is Healthcare-grade AI
Building on a rich history of developing AI for healthcare, IQVIA AI connects the right data, technology, and expertise to address the unique needs of healthcare. It's what we call Healthcare-grade AI.
LEARN MORE
Meet the IQVIA AI Assistant
Your new expert analyst is here. Be at the forefront of data-driven decision-making with a new generative AI tool that enables you to interact with our products and solutions like never before. Get results you can trust, faster.
LEARN MORE
Your healthcare data deserves more than just a cloud.
The IQVIA Human Data Science Cloud is our unique capability designed to enable healthcare-grade analytics, tools, and data management solutions to deliver fit-for-purpose global data at scale.
LEARN MORE
Innovations make an impact when bold ideas meet powerful partnerships
The IQVIA Innovation Hub connects start-ups with the extensive IQVIA network of assets, resources, clients, and partners. Together, we can help lead the future of healthcare with the extensive IQVIA network of assets, resources, clients, and partners.
LEARN MORE
Proven, faster DCT solutions
IQVIA Decentralized Trials deliver purpose-built clinical services and technologies that engage the right patients wherever they are. Our hybrid and fully virtual solutions have been used more than any others.
LEARN MORE
IQVIA Patient Experience Solutions with Apple devices
Empowering patients to personalize their healthcare and connecting them to caregivers has the potential to change the care delivery paradigm.
LEARN MOREIQVIA Careers
Featured Careers
Stay Connected
WE'RE HIRING
"At IQVIA your potential has no limits. We thrive on bold ideas and fearless innovation. Join us in reimagining what’s possible.
VIEW ROLESArticle
Obesity Market Revolution: Reshaping the Future of Metabolic Health
IQVIA Forecast Link
Jul 14, 2025
Obesity, once regarded as a lifestyle issue, has now escalated into a pressing global health crisis. By 2035, an estimated 1.53 billion adults globally are projected to be living with obesity (BMI ≥30 kg/m2). When combined with the overweight (BMI ≥25 to 30 kg/m2) adult population, the total number is expected to reach 3.3 billion - representing over 54% of the world's adult population. The financial impact is equally significant, with these conditions projected to reduce the global economy by more than US$4 trillion annually by 2035, equivalent to nearly 3% of global GDP.
In response, the pharmaceutical industry has undergone rapid transformation. What was once a niche market has become one of the fastest-growing sectors in healthcare, driven by scientific advancements, innovative therapies, and increasing demand. As new treatments emerge and the market expands, the future of obesity care is being reshaped, offering more effective solutions for weight management and metabolic health.
In 2020, global spending on anti-obesity medications (AOMs) stood at approximately US$3 billion. By 2024, that figure had soared to US$30+ billion - a more than tenfold increase in just four years. Given the current trend and the pace of innovation in the disease area, the market is expected to sustain its explosive growth well into the future. Between 2024 and 2034, the global AOM market is expected to grow at a CAGR of 13–15% and the total market size is expected to reach approximately US$130 billion. Biologics are leading the way in the obesity drug market, with GLP-1 and GIP receptor agonists holding the major share. However, non-biologics are expected to regain some market share in the forecast period as the market diversifies and new treatment options emerge.
The obesity market is transforming fast—are you ready? Download the article to uncover key drivers, pipeline trends, and strategic insights that can shape your next move in metabolic health.
In response, the pharmaceutical industry has undergone rapid transformation. What was once a niche market has become one of the fastest-growing sectors in healthcare, driven by scientific advancements, innovative therapies, and increasing demand. As new treatments emerge and the market expands, the future of obesity care is being reshaped, offering more effective solutions for weight management and metabolic health.
In 2020, global spending on anti-obesity medications (AOMs) stood at approximately US$3 billion. By 2024, that figure had soared to US$30+ billion - a more than tenfold increase in just four years. Given the current trend and the pace of innovation in the disease area, the market is expected to sustain its explosive growth well into the future. Between 2024 and 2034, the global AOM market is expected to grow at a CAGR of 13–15% and the total market size is expected to reach approximately US$130 billion. Biologics are leading the way in the obesity drug market, with GLP-1 and GIP receptor agonists holding the major share. However, non-biologics are expected to regain some market share in the forecast period as the market diversifies and new treatment options emerge.
The obesity market is transforming fast—are you ready? Download the article to uncover key drivers, pipeline trends, and strategic insights that can shape your next move in metabolic health.
Related solutions
MIDAS®
Analyze industry leading sales and medical data in a standardized and comparable way, including cross-country analysis of performance and additional insights into global and regional markets.
ChannelDynamics
Measure the performance of your sales force and marketing channels, adapt your commercial strategy and gain real world competitive insights.